Arax Advisory Partners’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$84.5K Buy
3,189
+191
+6% +$4.95K ﹤0.01% 2940
2026
Q2
$78.4K Buy
+2,998
New +$76.2K ﹤0.01% 2911
2026
Q1
– Sell
-169
Closed -$4.45K – 4395
2025
Q4
$4.45K Sell
169
-2,812
-94% -$61.3K ﹤0.01% 2923
2025
Q3
$50.9K Buy
+2,981
New +$42.7K ﹤0.01% 1828
2025
Q1
– Sell
-169
Closed -$2.48K – 3089
2024
Q4
$2.48K Sell
169
-47
-22% -$657 ﹤0.01% 1959
2024
Q3
$2.71K Hold
216
– – ﹤0.01% 1947
2024
Q2
$1.84K Buy
+216
New +$1.92K ﹤0.01% 1995

Other funds holding ZYME

Arax Advisory Partners's ZYME Position: Q3 2026 in Review

Arax Advisory Partners increased its Zymeworks (ZYME) stake by 6.4% in Q3 2026, buying an estimated $4.95K and bringing the position to 3,189 shares worth $84.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

Arax Advisory Partners first reported a position in ZYME in Q2 2024 and has held it in 7 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • Arax Advisory Partners held 3,189 shares of Zymeworks worth $84.5K as of Q3 2026.
  • Arax Advisory Partners bought 191 Zymeworks shares in Q3 2026, an estimated $4.95K.
  • Zymeworks made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2940 holding.
  • Arax Advisory Partners first reported a position in Zymeworks in Q2 2024 and has held it in 7 quarters since.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.